Global Digital Therapeutics Market
Market Size in USD Billion
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 4,300.00 Million |
 Market Size (Forecast Year) |
USD 20,421.08 Million |
 CAGR |
% |
| Major Markets Players |
Global Digital Therapeutics Market, By Product Type (Software and Devices), Sales Channel (B2C and B2B), Application (Preventive Applications and Treatment/Care-related Applications) – Industry Trends and Forecast to 2030.
Digital Therapeutics Market Analysis and Size
Digital therapeutics help deliver cheaper healthcare treatment and saves a good amount of time for the patient and the healthcare provider. Rising smartphone, tablet, and other similar device penetration, combined with rising healthcare applications and software, has fuelled demand for digital therapeutics and the outcomes can be witness with the growth of global digital therapeutics market. Digital therapeutics offer the potential to improve patient outcomes by providing evidence-based interventions, treatment plans, and monitoring that can be personalized to an individual's specific needs. This can lead to better disease management and overall health outcomes.
Data Bridge Market Research analyses that the global digital therapeutics market which was USD 4,300.00 million in 2022, expected to reach USD 20,421.08 million by 2030, and is expected to undergo a CAGR of 21.5% during the forecast period 2023-2030. “Software” dominates the product type segment of the global digital therapeutics market owing to the growing demand for better methods of bone related treatment. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Digital Therapeutics Market Scope and Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2023 to 2030 |
|
Base Year |
2022 |
|
Historic Years |
2021 (Customizable to 2015-2020) |
|
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
|
Segments Covered |
Product Type (Software and Devices), Sales Channel (B2C and B2B), Application (Preventive Applications and Treatment/Care-related Applications) |
|
Countries Covered |
U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E., Kuwait, Israel, Egypt, and Rest of Middle East and Africa |
|
Market Players Covered |
Omada Health, Inc. (U.S.), ResMed (U.S.), Pear Therapeutics, Inc. (U.S.), Solera Network (U.S.), Akili Interactive Labs, Inc. (U.S.), Better Therapeutics, LLC (U.S.), Biofourmis (U.S.), Click Therapeutics, Inc. (U.S.), Naturalcycles Nordic AB (Sweden), NuvoAir AB (Sweden), Welldoc’s Bluestar (U.S.), Happify, Inc. (U.S.), Limbix Health, Inc. (U.S.), Voluntis (U.S.), Xealth (U.S.) |
|
Market Opportunities |
|
Market Definition
Digital therapeutics is a part of digital healthcare that helps to prevent, manage and treat a medical condition. Moreover, it also aid in treating psychological conditions. Patient condition are improved a lot as it is evidence-based digital healthcare technology. Digital therapeutics technology is effective and efficient in diagnosing conditions that are not diagnosed otherwise by the healthcare system such as chronic diseases, neurological disorders, and much more.
Global Digital Therapeutics Market Dynamics
Drivers
- Rising of the Chronic Diseases
The high incidence of chronic diseases along with rising demand for controlled healthcare facilities and treatment costs has boosted the demand for digital therapeutics. For instance, cardiovascular disease (CVD) is leading to the death of 17.3 million people per year, and this is expected to cross 23.6 million by 2022.
- Launch of New Products
A strong line of potential products that are expected to be launched during the forecast period also provide emerging opportunities in the future. For instance, potential products of pear therapeutics, clinical therapeutics products in phase III are Pear-011 (anxiety GAD), Pear-015 (depression MDD) which are used in the treatment of chronic insomnia and depression and CT-152 (major depressive disorder), CT-155 (schizophrenia) are used in the treatment of schizophrenia and depression.
Opportunity
- Integration with Healthcare Systems
Digital therapeutics can seamlessly integrate with electronic health records (EHRs) and other healthcare systems, enabling healthcare providers to access and monitor patient data in real-time. This streamlining of healthcare delivery improves the efficiency of care and supports more effective decision-making. Integration with healthcare systems facilitates secure and standardized data sharing between digital therapeutics platforms and healthcare providers. This data exchange can include patient health records, treatment plans, medication adherence, and progress reports. Having access to this information helps healthcare providers make informed decisions.
Restraint/Challenge
- High Cost and Expenditure Involved
The huge expenditure required for manufacturing these therapeutics surely hamper the market growth. Several market players make huge investment in installing new and advanced therapeutics to faster the process and in return the cost is increased. Developing digital therapeutics involves significant expenses related to research, software development, clinical trials, and regulatory approvals. Companies must invest in technology, healthcare expertise, and data analytics to create effective solutions. These costs can be a barrier to entry for startups and smaller companies.
This global digital therapeutics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global digital therapeutics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In February 2022, Biofourmis announced the launch of Biofourmis Care, a technology-enabled care management service that delivers high quality remote care for patients with chronic conditions. The service includes automated medication management to augment and assist care teams in remotely adjusting medications for optimal personalized therapy. This strategic launch helped the company to improve health outcomes in the market and reduce total cost of care among patients, thereby gaining significant industry revenue.
Global Digital Therapeutics Market Scope
The global digital therapeutics market is segmented on the basis of product type, sales channel, and application. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Software
- Devices
Sales Channel
- B2B
- B2C
Application
- Preventive Applications
- Treatment/Care-related Applications
Global Digital Therapeutics Market Regional Analysis/Insights
The global digital therapeutics market is analysed and market size insights and trends are provided by country, product type, sales channel, and application as referenced above.
The countries covered in the global digital therapeutics market report are U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E., Kuwait, Israel, Egypt, and Rest of Middle East and Africa
North America dominates the bone global digital therapeutics market due to the strong base of healthcare facilities, the strong presence of major players in the market, the extraordinary healthcare infrastructure, and the large pool of people having chronic diseases.
Asia-Pacific is expected to witness significant growth in the global digital therapeutics market during the forecast period of 2023 to 2030 due to the increase in government initiatives to promote healthcare, the rising health awareness among the people and growing demand for advanced medical technology for chronic diseases, the large population pool, and the growing demand for quality healthcare in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends, and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The global digital therapeutics market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the global digital therapeutics market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on global digital therapeutics market. The data is available for historic period of 2015-2020.
Competitive Landscape and Global Digital Therapeutics Market Share Analysis
The global digital therapeutics market competitive landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width, and breadth, application dominance. The above data points provided are only related to the companies' focus related to the global digital therapeutics market.
Some of the major players operating in the global digital therapeutics market are:
- Omada Health, Inc. (U.S.)
- ResMed (U.S.)
- Pear Therapeutics, Inc. (U.S.)
- Solera Network (U.S.)
- Akili Interactive Labs, Inc. (U.S.)
- Better Therapeutics, LLC (U.S.)
- Biofourmis (U.S.)
- Click Therapeutics, Inc. (U.S.)
- Naturalcycles Nordic AB (Sweden)
- NuvoAir AB (Sweden)
- Welldoc’s Bluestar (U.S.)
- Happify, Inc. (U.S.)
- Limbix Health, Inc. (U.S.)
- Voluntis (U.S.)
- Xealth (U.S.)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
